Heidelberg Pharma AG (HPHA.DE)
EUR 2.7
(3.45%)
EUR 2.7
(3.45%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 5.83 Million EUR | -63.51% |
| 2022 | 15.98 Million EUR | 50.31% |
| 2021 | 10.63 Million EUR | 5145.56% |
| 2020 | 202.67 Thousand EUR | 0.0% |
| 2019 | - EUR | 0.0% |
| 2018 | - EUR | 0.0% |
| 2017 | - EUR | -100.0% |
| 2016 | 3.74 Million EUR | 0.0% |
| 2015 | - EUR | -100.0% |
| 2014 | 77.48 Thousand EUR | -97.19% |
| 2013 | 2.75 Million EUR | -7.53% |
| 2012 | 2.97 Million EUR | -72.97% |
| 2011 | 11.01 Million EUR | 18899.54% |
| 2010 | 57.99 Thousand EUR | 0.0% |
| 2009 | - EUR | -100.0% |
| 2008 | 15.35 Thousand EUR | 0.0% |
| 2007 | - EUR | 0.0% |
| 2006 | - EUR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 5.23 Million EUR | -10.18% |
| 2024 Q2 | 21.36 Million EUR | 307.96% |
| 2024 Q3 | 21.29 Million EUR | -99.25% |
| 2023 Q3 | 5.75 Million EUR | 2312.36% |
| 2023 Q2 | 238.7 Thousand EUR | 40.21% |
| 2023 Q1 | 170.24 Thousand EUR | -98.93% |
| 2023 FY | 5.83 Million EUR | -63.51% |
| 2023 Q4 | 5.83 Million EUR | 1.27% |
| 2022 Q4 | 15.98 Million EUR | 8398.58% |
| 2022 Q3 | 188.03 Thousand EUR | 30.23% |
| 2022 FY | 15.98 Million EUR | 50.31% |
| 2022 Q1 | 143.9 Thousand EUR | -98.65% |
| 2022 Q2 | 144.39 Thousand EUR | 0.34% |
| 2021 Q1 | 178.03 Thousand EUR | -12.16% |
| 2021 Q4 | 10.63 Million EUR | 8221.9% |
| 2021 Q2 | 153.08 Thousand EUR | -14.02% |
| 2021 FY | 10.63 Million EUR | 5145.56% |
| 2021 Q3 | 127.75 Thousand EUR | -16.55% |
| 2020 Q4 | 202.67 Thousand EUR | -9.5% |
| 2020 Q1 | 257.46 Thousand EUR | 0.0% |
| 2020 FY | 202.67 Thousand EUR | 0.0% |
| 2020 Q2 | 234.34 Thousand EUR | -8.98% |
| 2020 Q3 | 223.94 Thousand EUR | -4.44% |
| 2019 Q2 | - EUR | 0.0% |
| 2019 FY | - EUR | 0.0% |
| 2019 Q1 | - EUR | 0.0% |
| 2019 Q3 | - EUR | 0.0% |
| 2019 Q4 | - EUR | 0.0% |
| 2018 FY | - EUR | 0.0% |
| 2018 Q4 | - EUR | 0.0% |
| 2018 Q2 | - EUR | 0.0% |
| 2018 Q3 | - EUR | 0.0% |
| 2018 Q1 | - EUR | 0.0% |
| 2017 FY | - EUR | -100.0% |
| 2017 Q4 | - EUR | -100.0% |
| 2017 Q3 | 3.87 Million EUR | 338.07% |
| 2017 Q2 | 885.52 Thousand EUR | -76.49% |
| 2017 Q1 | 3.76 Million EUR | 0.51% |
| 2016 Q1 | - EUR | 0.0% |
| 2016 FY | 3.74 Million EUR | 0.0% |
| 2016 Q4 | 3.74 Million EUR | 0.0% |
| 2016 Q3 | - EUR | 0.0% |
| 2016 Q2 | - EUR | 0.0% |
| 2015 FY | - EUR | -100.0% |
| 2015 Q1 | 13.33 Thousand EUR | -82.79% |
| 2015 Q2 | 6593.00 EUR | -50.55% |
| 2015 Q3 | 1011.00 EUR | -84.67% |
| 2015 Q4 | - EUR | -100.0% |
| 2014 Q1 | 2.59 Million EUR | -5.62% |
| 2014 Q3 | 67.02 Thousand EUR | -97.45% |
| 2014 Q2 | 2.62 Million EUR | 1.19% |
| 2014 FY | 77.48 Thousand EUR | -97.19% |
| 2014 Q4 | 77.48 Thousand EUR | 15.61% |
| 2013 Q3 | 2.78 Million EUR | -0.26% |
| 2013 Q2 | 2.78 Million EUR | -0.5% |
| 2013 Q1 | 2.8 Million EUR | -5.9% |
| 2013 FY | 2.75 Million EUR | -7.53% |
| 2013 Q4 | 2.75 Million EUR | -0.98% |
| 2012 Q3 | 373.55 Thousand EUR | -96.51% |
| 2012 FY | 2.97 Million EUR | -72.97% |
| 2012 Q1 | 10.57 Million EUR | -4.04% |
| 2012 Q2 | 10.69 Million EUR | 1.18% |
| 2012 Q4 | 2.97 Million EUR | 697.14% |
| 2011 Q3 | 477.33 Thousand EUR | 75.98% |
| 2011 Q1 | 126.02 Thousand EUR | 117.32% |
| 2011 FY | 11.01 Million EUR | 18899.54% |
| 2011 Q4 | 11.01 Million EUR | 2208.29% |
| 2011 Q2 | 271.24 Thousand EUR | 115.23% |
| 2010 Q1 | - EUR | 0.0% |
| 2010 FY | 57.99 Thousand EUR | 0.0% |
| 2010 Q4 | 57.99 Thousand EUR | -62.36% |
| 2010 Q3 | 154.06 Thousand EUR | -8.17% |
| 2010 Q2 | 167.77 Thousand EUR | 0.0% |
| 2009 FY | - EUR | -100.0% |
| 2009 Q4 | - EUR | 0.0% |
| 2008 FY | 15.35 Thousand EUR | 0.0% |
| 2007 FY | - EUR | 0.0% |
| 2006 FY | - EUR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| BioNTech SE | 219.1 Million EUR | 97.338% |
| CureVac N.V. | 41.85 Million EUR | 86.069% |
| Biotest Aktiengesellschaft | 689.8 Million EUR | 99.155% |
| Biotest Aktiengesellschaft | 689.8 Million EUR | 99.155% |
| BRAIN Biotech AG | 4.65 Million EUR | -25.164% |
| Formycon AG | 29.48 Million EUR | 80.223% |
| Medigene AG | 2.95 Million EUR | -97.674% |